Use of Proxy Entities in Fraud Cases
- Jessica Zeff
- 7 days ago
- 3 min read
The U.S. Department of Justice announced the conviction of a physician involved in a conspiracy to defraud the Medicare program. The case centered on an intricate network of telemedicine companies, marketers, and DME suppliers who collectively submitted fraudulent claims to Medicare for medically unnecessary durable medical equipment (DME) and cancer genetic testing (CGx). The physician played a central role by signing prescriptions and orders without proper evaluation or any actual provider-patient relationship.
How the Scheme Worked
The conspiracy involved a deliberate and layered structure to exploit Medicare reimbursement:
Marketers and Call Centers: These entities targeted Medicare beneficiaries through unsolicited calls, advertisements, or inducements. Beneficiaries were often promised “free” genetic tests or equipment.
Telemedicine Entities: Once a beneficiary was identified, their information was routed to telemedicine platforms that often lacked any meaningful patient engagement. Providers would approve orders without real-time consultation or medical justification.
Physicians: In this case, the convicted physician admitted to signing thousands of orders for DME and CGx without evaluating patients, often relying solely on forms prefilled by marketers. The volume alone — thousands of orders in a short period — underscores the lack of clinical integrity.
DME Suppliers and Labs: These companies used the signed orders to submit claims to Medicare. By receiving “legitimate” documentation, they were able to process payments for unnecessary services under the appearance of compliance.
Key Compliance Concerns: Entity Relationships as Risk Multipliers
This case is a textbook example of how fraud schemes leverage formal relationships between entities to facilitate, obscure, and perpetuate illegal conduct. Several themes emerge:
1. The Illusion of Legitimacy Through Volume and Structure
Each entity involved appeared, on its own, to be conducting standard business operations: marketing services, telehealth consultations, physician oversight, or DME supply. However, when mapped together, the relationships expose a coordinated effort to defraud the government.
The takeaway for compliance professionals is this: fraud often manifests in the spaces between entities, particularly when there is weak or absent due diligence.
2. Breakdowns in Oversight
The participating entities capitalized on a lack of internal oversight. For example:
Physicians were not independently verifying medical necessity.
Telemedicine companies failed to implement robust credentialing and documentation standards.
DME suppliers relied on orders that were clearly generated without a legitimate clinical evaluation.
In legitimate organizations, compliance programs must establish controls for referral source validation, order justification, and inter-entity audit trails.
3. Use of Proxy Entities to Evade Detection
By routing orders through third parties — and sometimes even different corporate shells — the scheme intentionally distanced the “dirty hands” from the claims themselves. This obfuscation tactic remains common in healthcare fraud, particularly in DME and laboratory billing.
Lessons for Compliance Leaders
This case underscores several key action areas for healthcare compliance programs:
Relationship Mapping: Maintain a documented matrix of all vendors, referral sources, contractors, and ordering entities. Understand who is doing what — and on whose behalf.
Enhanced Due Diligence: Don’t rely on documentation alone. Verify the source, the context, and the appropriateness of relationships — especially for high-risk services like genetic testing, DME, or telehealth.
Volume Monitoring: Pay attention to unusually high ordering patterns, particularly from providers with limited or no patient encounters.
Segregation of Duties: If your organization provides telemedicine services, ensure that marketing, clinical review, and ordering are not influenced by the same individuals or entities.
Whistleblower Readiness: Many recent fraud cases were initiated by insiders. Compliance programs must foster environments where staff feel safe reporting concerns related to inter-entity activities.
Final Reflection: The Role of Inter-Entity Controls in Preventing Fraud
As this case demonstrates, healthcare fraud is increasingly carried out through networks of entities that exploit weaknesses in documentation, oversight, and verification. The physician may have signed the orders — but the enabling infrastructure was built by the web of marketers, telehealth facilitators, and suppliers.
As compliance professionals, we must not only look inward but also outward — toward the ecosystem of relationships we participate in and facilitate. The consequences of inaction are clear: significant financial loss to federal programs, reputational harm, and patient trust erosion.
Comments